A halin yanzu, da cutar ta sau da yawa ta zazzabi kuma kwayar cutar ta akai-akai. A cewar ƙididdiga sun saki kan Nuwamba 10, yawan laifin COVID-19 a duk duniya ya karu da sama da 540,000 a duk da haka, da kuma karar karar ta wuce miliyan 250 miliyan suka wuce miliyan 250. COVID-19 yana ɗaukar adadin da ba a taɓa ganin lafiyar mutane da tattalin arzikin mutane a duniya ba. Cin nasara da annoba a farkon ranar da kuma dawo da ci gaban tattalin arziki shine babban fifikon al'ummomin kasa da kasa. Yin hukunci daga rigakafin cututtukan daji na gaba, akwai babban kasuwa bukatar covid-19 products antigen kayayyaki.
Kwanan nan, Mototarvirus (SARS-CORV-2) Antigen Antigen Rapid (Colloidal zinare) ta manyan kifin a cikin EUungiyar Tarayyar Turai. Bayan samun takaddun shaida, yana iya samun takardar shaidar CE.
Littattafai (SARKIN-COV-2) Antigen Rapid (Colloidal Zinare yana da sauƙin aiki. Akwai saurin gano m.
Fuskokin Coronavirus Coronavirus, Bigffish zai mayar da hankali kan fasahar core fasahar tare da tsauraran aiki da na gaske. Za mu samar da kyawawan samfurori da ayyuka don bayar da gudummawa ga rigakafin cutar ta bakin ciki da sarrafawa kan lafiyar ɗan adam.
Lokaci: Dec-10-2021